Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Genomics Data|October 21, 2015
Small molecule inhibition of FOXM1: How to bring a novel compound into genomic contextGiovanni Marsico, Michael V Gormally
Langmuir : the ACS Journal of Surfaces and Colloids|September 11, 2008
Dual-beam polarization interferometry resolves mechanistic aspects of polyelectrolyte adsorptionThomas J Lane, Will R Fletcher, Michael V Gormally, et al.
Chemical Communications (Cambridge, England)|August 17, 2013
Light-mediated in cell downregulation of G-quadruplex-containing genes using a photo-caged ligandPierre Murat, Michael V Gormally, Debbie Sanders, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|September 9, 2011
Enhanced iron availability by protein glycation may explain higher infection rates in diabeticsTheodore J Zwang, Michael V Gormally, Malkiat S Johal, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|June 10, 2009
Controlling tyrosinase activity on charged polyelectrolyte surfaces: a QCM-D analysisMichael V Gormally, Rebecca K McKibben, Malkiat S Johal, et al.
Genome Biology|June 24, 2015
FOXM1 binds directly to non-consensus sequences in the human genomeDeborah A Sanders, Michael V Gormally, Giovanni Marsico, et al.
Journal for Immunotherapy of Cancer|September 10, 2025
Allele-specific HLA LOH in solid tumors: distinct patterns by tumor type and potential prognostic relevanceTomasz Sewastianik, Christian Roy, Michael V Gormally, et al.
Plos One|July 28, 2021
Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19Neima Briggs, Michael V Gormally, Fangyong Li, et al.
Nature Communications|November 13, 2014
Suppression of the FOXM1 transcriptional programme via novel small molecule inhibitionMichael V Gormally, Thomas S Dexheimer, Giovanni Marsico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing SarcomaChristine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
Pageof 2